- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04394585
Effect of Smart Phone App-based Human Coaching Program in Gastrectomized Patients
A Study Evaluating Effect of Smart Phone App-based Human Coaching Program on QOL in Patients Who Underwent Gastrectomy for Stage I Gastric Cancer
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
< Patient enrollment>
- 90 patients in each group, a total of 180 patients
- 1:1 Randomization using permutated mixed block randomization
- stratified by surgical extent (distal gastrectomy vs. total gastrectomy)
- using nQuery program and web-based management system
- Before discharge, patients are informed how to use the smart phone app and registered to the app.
- Patients use the app after discharge until 3 months postoperatively.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Bang Wool Eom, PhD
- Phone Number: 82-31-920-1689
- Email: kneeling79@ncc.re.kr
Study Contact Backup
- Name: Hyunju Cho
- Phone Number: 82-31-920-0661
- Email: 74093@ncc.re.kr
Study Locations
-
-
Gyeonggi-do
-
Goyang, Gyeonggi-do, Korea, Republic of, 10408
- Recruiting
- Bang Wool Eom
-
Contact:
- Hong Man Yoon, MD
- Phone Number: 8-31-920-1710
- Email: red10000@ncc.re.kr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- patient aged 19 or more
- patient diagnosed as stage I in preoperative examination
- planned distal gastrectomy or total gastrectomy
- patient who can use smart phone app or whose family can help the
- patient to use the smart phone app
Exclusion Criteria:
- pregnant
- disabled to communication
- patient who cannot use smart phone app
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Smart phone app group
Patients used smart phone app based human coaching program for 3 months postoperatively.
|
|
Active Comparator: Nutritional consultation group
Patients have two consulting with clinical nutritionist at 1 month and 3 months postoperatively.
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Eating restriction score (XEatR) at 3 months postoperatively
Time Frame: 3 months postoperatively
|
Eating resection scale is calcuated according to the following equation.
XEatR = (EatR-1)*100/3 The 4 items are belong to European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ) STO22. Each item has a value among 1, 2, 3, and 4 according to the answer and the scale score has a value ranging 0 (minimum) to 100 (maximum). Higher scores mean having more symptom and worse quality of life. |
3 months postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Eating restriction score (XEatR) at 6 months postoperatively
Time Frame: 6 months postoperatively
|
Eating resection scale is calcuated according to the following equation.
XEatR = (EatR-1)*100/3 The 4 items are belong to European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ) STO22. Each item has a value among 1, 2, 3, and 4 according to the answer and the scale score has a value ranging 0 (minimum) to 100 (maximum). Higher scores mean having more symptom and worse quality of life. |
6 months postoperatively
|
Eating restriction score (XEatR) at 12 months postoperatively
Time Frame: 12 months postoperatively
|
Eating resection scale is calcuated according to the following equation.
XEatR = (EatR-1)*100/3 The 4 items are belong to European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ) STO22. Each item has a value among 1, 2, 3, and 4 according to the answer and the scale score has a value ranging 0 (minimum) to 100 (maximum). Higher scores mean having more symptom and worse quality of life. |
12 months postoperatively
|
food intake
Time Frame: discharge day: up to 3 weeks postoperatively,1 month postoperatively
|
difference of food amount between discharge day and postoperative 1 month
|
discharge day: up to 3 weeks postoperatively,1 month postoperatively
|
Body weight
Time Frame: 3 months postoperatively
|
patient's weight in kilograms
|
3 months postoperatively
|
serum albumin
Time Frame: 3 months postoperatively
|
g/dL
|
3 months postoperatively
|
serum protein
Time Frame: 3 months postoperatively
|
g/dL
|
3 months postoperatively
|
serum cholesterol
Time Frame: 3 months postoperatively
|
g/dL
|
3 months postoperatively
|
seum hemoglobin
Time Frame: 3 months postoperatively
|
g/dL
|
3 months postoperatively
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1910242
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stage I Gastric Cancer
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingGastric Adenocarcinoma | Clinical Stage III Gastric Cancer AJCC v8 | Clinical Stage 0 Gastric Cancer AJCC v8 | Clinical Stage I Gastric Cancer AJCC v8 | Clinical Stage II Gastric Cancer AJCC v8 | Clinical Stage IIA Gastric Cancer AJCC v8 | Clinical Stage IIB Gastric Cancer AJCC v8 | Pathologic Stage... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingGastric Adenocarcinoma | Clinical Stage III Gastric Cancer AJCC v8 | Clinical Stage I Gastric Cancer AJCC v8 | Clinical Stage IIA Gastric Cancer AJCC v8 | Clinical Stage IVA Gastric Cancer AJCC v8 | Pathologic Stage IB Gastric Cancer AJCC v8 | Pathologic Stage II Gastric Cancer AJCC v8 | Pathologic... and other conditionsUnited States
-
City of Hope Medical CenterRecruitingGastric Cancer | Gastric Adenocarcinoma | Gastric Cancer Stage IV | Gastric Neoplasm | Gastric Cancer Metastatic to Lung | Gastric Cancer Stage | Gastric Cancer Metastatic to Liver | Gastric Cancer Stage III | Gastric Cancer Stage II | Gastric Lesion | Gastric Cancer in Situ | Gastric Cancer Stage IIIB | Gastric... and other conditionsUnited States, Japan
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
National Cancer Institute (NCI)RecruitingGastric Adenocarcinoma | Clinical Stage III Gastric Cancer AJCC v8 | Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Gastroesophageal Junction Adenocarcinoma | Clinical Stage I Gastric Cancer AJCC v8 | Clinical Stage II Gastric Cancer AJCC v8 | Clinical Stage IVA Gastric... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingGastric Adenocarcinoma | Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Clinical Stage 0 Gastric Cancer AJCC v8 | Clinical Stage I Gastric Cancer AJCC v8 | Clinical Stage IIB Gastric Cancer AJCC v8 | Clinical Stage IVA Gastric Cancer AJCC v8 | Pathologic Stage 0 Gastric... and other conditionsUnited States
-
Affiliated Hospital of Nantong UniversityTongzhou District Hospital; Haimen People's Hospital; Dongtai People's Hospital; Qidong City People's Hospital and other collaboratorsRecruitingGastric Cancer Stage IChina
-
Thomas Jefferson UniversityNational Cancer Institute (NCI)CompletedStage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Clinical Stage III Gastric Cancer AJCC v8 | Clinical Stage IV Gastric Cancer AJCC v8 | Stage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer... and other conditionsUnited States
-
Ohio State University Comprehensive Cancer CenterNot yet recruitingGastric Adenocarcinoma | Clinical Stage III Gastric Cancer AJCC v8 | Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Clinical Stage I Gastric Cancer AJCC v8 | Clinical Stage II Gastric Cancer AJCC v8 | Clinical Stage IIA Gastric Cancer AJCC v8 | Clinical Stage IIB Gastric... and other conditionsUnited States
-
City of Hope Medical CenterActive, not recruitingAdenocarcinoma of the Gastroesophageal Junction | Stage IV Gastric Cancer | Recurrent Gastric Cancer | Diffuse Adenocarcinoma of the Stomach | Intestinal Adenocarcinoma of the Stomach | Mixed Adenocarcinoma of the Stomach | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric Cancer and other conditionsUnited States
Clinical Trials on smart phone app based human coaching program
-
The Miriam HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Kaohsiung Veterans General Hospital.Completed
-
Kaohsiung Medical University Chung-Ho Memorial...Completed
-
Singapore General HospitalSingHealth Polyclinic - Sengkang; SingHealth Polyclinic - Punggol; SingHealth... and other collaboratorsRecruitingApp-based Motivational Interviewing and Artificial Intelligence in Diabetes Management (EmpowerPlus)Diabetes Mellitus Type 2Singapore
-
Harvard School of Dental MedicineNot yet recruitingDiabetes Mellitus | Periodontal Diseases
-
Kaohsiung Medical University Chung-Ho Memorial...Completed
-
First Affiliated Hospital Xi'an Jiaotong UniversityTerminated
-
Peking University People's HospitalPeking UniversityUnknownKnee Osteoarthritis | Arthroplasty, Replacement, Knee
-
University of ZurichCompletedGrowth and DevelopmentSwitzerland
-
The Miriam HospitalCompleted